COX-2, the rate-limiting enzyme in PGE2 synthesis, is overexpressed in several cancers including BC (reviewed in [137]), and PGE2 exerts diverse effects on cell proliferation, apoptosis, angiogenesis, inflammation, and immunosuppression [136]. This evidence concerns the gene PTGS2 and breast cancer.